Skip to main content

Table 5 Independent prognostic factors of OS and CSS in post-chemotherapy PTL patients via univariate and multivariate Cox regression analysis

From: Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study

 

(A) Univariate Analysis

(B) Multivariate Analysis

Overall Survival

Cancer-Specific Survival

Overall Survival

Cancer-Specific Survival

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

Sex

 Male vs. Female

1.15(0.92–1.43)

0.213

1.01(0.71–1.43)

0.969

/

/

/

/

Age at diagnosis

  < 65 vs. > = 65

4.74(3.72–6.03)

< 0.001

0.26(0.18–0.39)

< 0.001

4.45(3.47–5.69)

< 0.001

3.84(2.60–5.69)

< 0.001

Race

 White vs. Black

1.13(0.59–2.20)

0.710

1.46(0.54–3.94)

0.458

/

/

/

/

 White vs. Others

1.31(0.91–1.88)

0.147

1.31(0.73–2.38)

0.365

/

/

/

/

Marital status

 Unmarried vs. Married

0.60(0.49–0.73)

< 0.001

0.94(0.68–1.31)

0.720

0.74(0.60–0.90)

0.003

/

/

Classification

 HL vs. Aggressive B cell NHL

4.47(1.11–17.94)

0.035

1.53(0.38–6.19)

0.551

2.20(0.54–8.91)

0.270

/

/

 HL vs. Indolent B cell NHL

2.77(0.67–11.41)

0.158

0.55(0.12–2.50)

0.437

1.52(0.37–6.30)

0.565

/

/

 HL vs. T cell NHL

9.54(1.34–67.88)

0.024

3.32(0.30–36.67)

0.328

6.43(0.90–45.87)

0.063

/

/

 HL vs. NHL-NOS

5.16(1.23–21.58)

0.025

1.49(0.33–6.80)

0.608

2.15(0.51–9.08)

0.298

/

/

 HL vs. Others

5.49(1.22–24.77)

0.027

1.78(0.33–9.74)

0.504

2.81(0.62–12.78)

0.183

/

/

Lymphoma Ann Arbor Stage

 Stage I vs. Stage II

0.96(0.76–1.20)

0.730

1.39(0.96–2.01)

0.078

1.07(0.86–1.34)

0.527

1.48(1.02–2.13)

0.038

 Stage I vs. Stage III

0.98(0.59–1.63)

0.936

1.41(0.64–3.10)

0.394

0.92(0.55–1.53)

0.736

1.21(0.55–2.68)

0.636

 Stage I vs. Stage IV

1.58(1.16–2.15)

0.003

2.20(1.35–3.59)

0.002

1.19(0.87–1.62)

0.279

1.69(1.03–2.77)

0.039

Surgery

 No vs. Performed

0.70(0.58–0.86)

< 0.001

0.75(0.54–1.04)

0.085

0.82(0.67–1.00)

0.050

/

/

Radiation

 No vs. Performed

0.66(0.55–0.81)

< 0.001

0.56(0.40–0.79)

0.001

0.64(0.53–0.79)

< 0.001

0.56(0.40–0.79)

0.001

  1. Abbreviations: HR, Hazard Ratio; CI, Confidence Interval; HL, Hodgkin lymphoma; NHL, Non-Hodgkin Lymphoma; NOS, Not Otherwise Specified